Hepatitis viruses A, B, C, D, E and G: Implications for dental personnel

Journal of the American Dental Association

Volumn 130, Issue 4, 1999, Pages 509-520

  Gillcrist, James A ^a  

^a TENNESSEE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS VACCINE;

CHRONIC HEPATITIS; DENTIST; DISEASE TRANSMISSION; GOVERNMENT; HEPATITIS VIRUS; HUMAN; INFECTION CONTROL; LEGAL ASPECT; OCCUPATIONAL EXPOSURE; PATHOLOGY; REVIEW; UNITED STATES; VIROLOGY; VIRUS HEPATITIS;

ANTIVIRAL AGENTS; DENTAL STAFF; HEPATITIS VIRUSES; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INFECTION CONTROL, DENTAL; INTERFERON-ALPHA; OCCUPATIONAL EXPOSURE; UNITED STATES; UNITED STATES OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION; VIRAL HEPATITIS VACCINES;

EID: 0033113971     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1999.0245     Document Type: Article

References (97)

1. Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741-6.
2. Zuckerman AJ. The history of viral hepatitis from antiquity to the present. In: Deinhardt F, Deinhardt J, eds. Viral hepatitis: Laboratory and clinical science. New York: Marcel Dekker; 1983:3-32.
3. Battegay M, Feinstone SM. Hepatitis A virus. In: Willson RA, ed. Viral hepatitis: Diagnosis, treatment, prevention. New York: Marcel Dekker; 1997:35-84.
4. Battegay M, Gust ID, Feinstone SM. Hepatitis A virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995:1636-56.
5. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the advisory committee on immunization practices (ACIP). MMWR 1996;45(RR-15):1-30.
6. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994;23:437-55.
7. Margolis HS, Alter MJ. Will hepatitis A Decome a vaccine-preventable disease? Ann Intern Med 1995;122:464-5.
8. Feinstone SM. Hepatitis A: epidemiology and prevention. Eur J Gastroenterol Hepatol 1996;8:300-5.
9. Cohen JI, Feinstone S, Purcell RH. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis 1989;160:887-90.
10. National Center for Health Statistics. Plan and operation of the third national Health and Nutrition Examination Survey, 1988-94. Hyattsville, Md.: National Center for Health Statistics; 1994. DHHS publication (PHS) 94-1308.
11. Centers for Disease Control and Prevention. Hepatitis A fact sheet. Available at: "http://www.cdc.gov/ncidod/diseases/ hepatitis/a/fact.htm". Accessed Feb. 19, 1999.
12. Stokes N Jr. The prevention and attenuation of infectious hepatitis by gamma globulin. JAMA 1945;127:144-5.
13. Stapelton JT. Passive immunization against hepatitis A. Vaccine 1992;10(suppl 1):45-7.
14. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;336:196-204.
15. Centers for Disease Control and Prevention. Immunization of health-care workers: Recommendations of the advisory committee on immunization practices (ACIP) and the hospital infection control practices advisory committee (HICPAC). MMWR 1997;46(RR-18):1-44.
16. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994;91:10198-202.
17. Mast EE, Krawczynski K. Hepatitis E: an overview. Annu Rev Med 1996;47:257-66.
18. Hoofnagle JH. Therapy of acute and chronic viral hepatitis. Adv Intern Med 1994;39:241-75.
19. Purdy MA, Krawczynski K. Hepatitis E. Gastroenterol Clin North Am 1994;23:537-46.
20. Centers for Disease Control and Prevention. Hepatitis E among U.S. travelers 1989-1992. MMWR 1993;42:1.
21. Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview. Semin Virol 1993;4:273-83.
22. Muraskin W. The war against hepatitis B: A history of the international task force on hepatitis B immunization. Philadelphia: University of Pennsylvania Press; 1995:1-248.
23. London TW, Evans AA. The epidemiology of hepatitis viruses B, C, and D. Clin Lab Med 1996;16:251-71.
24. Centers for Disease Control and Prevention. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the immunization practices advisory committee (ACIP). MMWR 1991;40(RR-13):1-25.
25. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603.
26. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA 1990;263:1218-22.
27. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission Dy immunization: an economic analysis of current recommendations. JAMA 1995;274:1201-8.
28. Centers for Disease Control and Prevention. Hepatitis Surveillance Report 1996;56:1-33.
29. Centers for Disease Control and Prevention. Hepatitis B fact sheet. Available at: "http://www.cdc.gov/ncidod/diseases/ hepatitis/b/fact.htm". Accessed Feb. 19, 1999.
30. Alter HJ, Purcell RH, Gerin JL, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun 1977;16:928-33.
31. Bancroft WH, Snitbhan R, Scott RM, et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis 1977;135:79-85.
32. MacQuarrie MB, Forghani B, Wolochow DA. Hepatitis B transmitted by a human bite. JAMA 1974;237:723-4.
33. Centers for Disease Control and Prevention. Lack of transmission of hepatitis B to humans after oral exposure to hepatitis B surface antigen-positive saliva. MMWR 1978;27:247-8.
34. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med 1996;100:41-5.
35. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
36. Hadler SC, Francis DP, Maynard JE, et al. Long term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
37. Siew C, Gruninger SE, Mitchell EW, Burrell KH. Survey of hepatitis B exposure and vaccination in volunteer dentists. JADA 1987;114:457-9.
38. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993;270:2935-9.
39. Centers for Disease Control and Prevention. FDA approval for infants of a Haemophilus influenza type b conjugate and hepatitis B (recombinant) combined vaccine. MMWR 1997;46:107-9.
40. Cleveland JL. Hepatitis B vaccination and infection among U.S. dentists, 1983-1992. JADA 1996;127:1385-90.
41. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among iealth care workers in the United States. Arch Intern Med 1997;157:2601-5.
42. Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission - United States. MMWR 1995;44:574-5.
43. Polish LB, Gallagher M, Fields HA, Hadler SC. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993;6:211-29.
44. Rizzetto M. The delta agent. Hepatology 1983;3:729-37.
45. Di Bisceglie AM. Hepatitis D virus. In: Willson RA, ed. Viral hepatitis: Diagnosis, treatment, prevention. New York: Marcel Dekker; 1997:217-38.
46. Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of hepatitis B. Lancet 1982;2:945-7.
47. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993;342:1335-40.
48. Hsu HH, Feinstone SM, Hoofnagle JH. Acute viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995:1136-59.
49. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
50. Davis GL. Hepatitis C virus. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases: Update 10. New York: Churchill Livingstone; 1991:3-11.
51. Esteban JI, Gömez J, Martell M, Guardia J. Hepatitis C. In: Willson RA, ed. Viral hepatitis: Diagnosis, treatment, prevention. New York: Marcel Dekker; 1997:147-216.
52. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125:658-68.
53. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: Rates, routes, and cofactors. Epidemiol Rev 1996;18:137-47.
54. NIH Concensus Development Conference on Management of Hepatitis C. Management of hepatitis C. Bethesda, Md.: National Institutes of Health; 1997.
55. Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1995;15:5-14.
56. Terrault N, Wright T. Interferon and hepatitis C. N Engl J Med 1995;332:1509-11.
57. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-40.
58. Alter MJ. Epidemiology of hepatitis C. Eur J Gastroenterol Hepatol 1996;8:319-23.
59. Tedeschi V, Seeff LB. Diagnostic tests for hepatitis C: Where are we now? Ann Intern Med 1995;123:383-4.
60. Murphy EL, Bryzman S, Williams AE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000.
61. Piazza M, Sagliocca L, Tosone G, et al. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. Arch Intern Med 1997;157:1537-44.
62. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(RR-19):1-39.
63. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into the conjunctiva (letter). Scand J Infect Dis 1993;25:270-1.
64. Komiyama K, Moro I, Mastuda Y, et al. HCV in saliva of chronic hepatitis patients laving dental treatment. Lancet 1991;338:572-3.
65. Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990;336:503-4.
66. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991;338:1539-42.
67. Kuo MYP, Hahn LJ, Hong CY, Kao JH, Chen DS. Low prevalence of hepatitis C virus infection among dentists in Taiwan. J Med Virol 1993;40:10-4.
68. Herbert AM, Walker DM, Davies KG, Bagg J. Occupationally acquired hepatitis C infection. Lancet 1992;339:305.
69. Puro V, Petrosillo N, Ippolito G, Aloisi MS, Boumis E, Ravà L. Occupational hepatitis C virus infection in Italian health care workers. Am J Public Health 1995;85:1272-5.
70. Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997;336:919-22.
71. Centers for Disease Control and Prevention. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. MMWR 1997;46:603-6.
72. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996;334:1536-7.
73. Di Bisceglie AM. Hepatitis G virus infection: a work in progress. Ann Intern Med 1996;125:772-3.
74. Tepper ML, Gully PR. Viral hepatitis: know your D, E, F and Gs. Can Med Assoc J 1997;156:1735.
75. Cheung RC, Keefe EB, Greenberg HB. Hepatitis G virus: is it a hepatitis virus? West J Med 1997;167:23-33.
76. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747-54.
77. Moaven LD, Tennakoon PS, Bowden DS, Locarnini SA. Mother-to-baby transmission of hepatitis G virus. Med J 1996;165:84-5.
78. Cheung RC, Keeffe EB. Hepatitis G virus: clinical relevance and responsiveness to interferon. Am J Gastroenterol 1997;92:1957-9.
79. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993;119:312-23.
80. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
81. Farci P, Mandas A, Coiana A, et al. Treatment of chronic hepatitis D with Interferon alfa-2a. N Engl J Med 1994;330:88-94.
82. Battegay M, Simpson LH, Hoofnagle JH, Sallie R, Di Bisceglie AM. Elimination of hepatitis D virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis. J Med Virol 1994;44:389-92.
83. Benhamou Y, Katlama C, Lunel F, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996;125:705-11.
84. Lee W. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
85. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three Interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62.
86. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominga T, Persing DH. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996;125:634-9.
87. Brillanti S, Garson J, Foli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994;107:812-7.
88. Di Bisceglie AM, Conjeevaram HS, Fried MW, et al. Ribavirin as therapy for chronic hepatitis C. Ann Intern Med 1995;123:897-903.
89. U.S. Food and Drug Administration. Approval letter. Available at: "http://www.fda. gov/cder/foi/appletter/1998/20903s1ltr.pdf". Accessed Feb. 20, 1999.
90. Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996;125:740-3.
91. American Dental Association. ADA fact sheets. Available at: "http://www.ada.org/ prac/careers/fs-dhyg.html". Accessed June 1998.
92. 29 CFR Part 1910.1030, Occupational exposure to bloodborne pathogens, final rule. Department of Labor, Occupational Safety and Health Administration. Fed Regist 1991;56(235):64004-182.
93. U.S. Department of Labor, Occupational Safety and Health Administration. Controlling occupational exposure to blood-borne pathogens in dentistry. Washington, D.C.: OSHA publications office; 1992. OSHA publication 3129.
94. Centers for Disease Control and Prevention. Recommended infection-control practices for dentistry, 1993. MMWR 1993;41(RR-8):1-12.
95. ADA Council on Scientific Affairs, ADA Council on Dental Practice. Infection control recommendations for the dental office and the dental laboratory. JADA 1996;127(5):672-80.
96. Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR 1991;40(RR-8):1-6.
97. American Dental Association. Resource manual for support of dentists with HBV, HIV, TB and other infectious diseases. Available at: "http://www.ada.org/prac/pubs/ hiv-man/legal.html". Accessed June 1998.